Barnes & Thornburg has advised BrightSpring Health Services. Latham & Watkins has advised the underwriter. BrightSpring Health Services, a provider of home and community-based health services,...
BrightSpring Health Services Completes $881 Million Secondary Offering
CenterWell Acquires MaxHealth From Arsenal Capital Partners
Sidley Austin LLP has advised Arsenal Capital Partners and MaxHealth in the sale of MaxHealth to CenterWell, the healthcare services division of Humana Inc. Latham &...
Summit Partners Makes Growth Investment in RIS Rx
Kirkland & Ellis along with DLA Piper has advised Summit Partners on the transaction, and Latham & Watkins has advised RIS Rx. Summit Partners has announced...
BrightSpring Health Services Completes $304.5 Million Secondary Offering
Barnes & Thornburg LLP has advised BrightSpring Health Services. Latham & Watkins LLP has advised the underwriters. BrightSpring Health Services, Inc., a leading provider of home...
Boston Scientific’s Acquisition of SoniVie Ltd.
Latham & Watkins advised Boston Scientific, while K&L Gates advised SoniVie Ltd. on the transaction. Boston Scientific Corporation (NYSE: BSX) announced it has entered into a...
Concentra’s $529 Million Initial Public Offering
Dechert advised Select Medical Holdings Corporation and Concentra Group Holdings Parent, Inc. on the transaction, while Latham & Watkins advised the underwriters. Medical Holdings Corporation (“Select...
Ardent Health’s $192 Million IPO
Sidley Austin represented Ardent Health Partners, Inc. in the offering, and Latham & Walkins represented the underwriters. Ardent Health Partners, Inc. (f/k/a Ardent Health Partners, LLC...
Warburg Pincus’ US$1 Billion Investment in Everise
Latham & Watkins advised Warburg Pincus; Kirkland & Ellis acted for Everise. Warburg Pincus, a leading global growth investor, completed a US$1 billion investment in Everise, a leading...
Omada Health’s $80 Million Growth Financing
Latham & Watkins advises Omada Health on growth financing. Omada Health, Inc., a virtual-first healthcare provider that implements clinically-validated behavior change protocols for individuals living with...
Health Care Service Corporation’s Acquisition of Trustmark Health Benefits
Foley & Lardner LLP represented Health Care Service Corporation (HCSC) on the deal, while Latham & Watkins LLP represented Trustmark in the transaction. Health Care Service Corporation...
Arcutis Biotherapeutics’ $150 Million Shares Offering
Latham & Watkins advised Arcutis Biotherapeutics, Inc. in the offering, while Cooley represented the underwriters. Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT) has announced the pricing of its underwritten...
Patient Square Capital’s $1.25 Billion Acquisition of Hanger
Kirkland & Ellis, Greenberg Traurig, and Latham & Watkins advised Patient Square Capital, Foley & Lardner advised Hanger, Proskauer Rose advised Ares Capital Management LLC on...